• English

Publications

2011
A. Cass, (Plenary speaker) Bex, flies and audiotapes – Jacquot Award Presentation, in 47th Annual Scientific Meeting of the Australia and New Zealand Society of Nephrology, Adelaide, Australia, September, 2011.
A. Cass, (Plenary speaker) Closing the Gap for Indigenous Australians with chronic kidney disease: Research, policy and practice, in Australian Association for Clinical Biochemistry Indigenous Health Symposium, Brisbane, Australia, November, 2011.
A. Cass, (Plenary speaker) Facilitating Indigenous Australians’ access to medicines and necessary care, in 3rd Joint Medicines Policy Conference, Canberra, Australia, August, 2011.
A. Cass, (Plenary Speaker) Kidney disease in 2020: a dialysis unit in every GP super clinic? , in Australasian Dialysis Nephrology Transplant Workshop, Pokolbin, Australia, March, 2011.
A. Cass, (Plenary speaker) “The door is locked. They sit behind closed doors”: Qualitative research to understand and address barriers to better kidney health , in 8th International Workshop on Kidney Disease in Indigenous, Minority, and Disadvantaged Populations, Victoria B.C., Canada, April, 2011.
B. Costa, I. Ranasinghe, A. Patel, A. Brown, A. Cass, L. Kritharides, D. Chew, J. French, F. Turnbull, D. Walters, I. Meredith, and D. Brieger, Rationale for the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE), CSANZ, vol. 20. Heart, Lung & Circulation 2011;20:S40, Perth, Australia, August, p. S40, 2011.
A. Cass, Simpler solutions to prevent chronic disease: A polypill-based strategy to prevent major cardiovascular events. , in ASEANZ Cardiovascular and Lipid Forum, Melbourne, Australia, 2011.
E. L. Heeley, J. W. Wei, K. N. Carter, M. S. Islam, A. G. Thrift, G. J. Hankey, A. Cass, and C. Anderson, Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand, Medical Journal of AustraliaMedical Journal of Australia, vol. 195, pp. 10-4, 2011.
A. Cass, The Central Australia Renal Study – Can we provide Sustainable and appropriate renal services to Aboriginal people from remote communities across the region? , in South Australia Renal Group, Adelaide, Australia , 2011.
J. Myburgh, R. Bellomo, A. Cass, S. R. Finfer, J. French, D. Gattas, P. Glass, J. Lee, J. Lipman, B. Liu, C. McArthur, S. McGuinness, D. Rajbhandari, C. Taylor, and S. Webb, The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality, Intensive Care Medicine, vol. 37, pp. 816-23, 2011.
C. Baigent, M. J. Landray, C. Reith, J. Emberson, D. C. Wheeler, C. Tomson, C. Wanner, V. Krane, A. Cass, J. Craig, B. Neal, L. Jiang, L. S. Hooi, A. Levin, L. Agodoa, M. Gaziano, B. Kasiske, R. Walker, Z. A. Massy, B. Feldt-Rasmussen, U. Krairittichai, V. Ophascharoensuk, B. Fellstrom, H. Holdaas, V. Tesar, A. Wiecek, D. Grobbee, D. de Zeeuw, C. Gronhagen-Riska, T. Dasgupta, D. Lewis, W. Herrington, M. Mafham, W. Majoni, K. Wallendszus, R. Grimm, T. Pedersen, J. Tobert, J. Armitage, A. Baxter, C. Bray, Y. Chen, Z. Chen, M. Hill, C. Knott, S. Parish, D. Simpson, P. Sleight, A. Young, and R. Collins, The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial, Lancet, vol. 377, pp. 2181-92, 2011.
S. Jan, T. Usherwood, J. A. Brien, D. Peiris, J. Rose, N. Hayman, K. Howard, J. Redfern, T. Laba, A. Cass, and A. Patel, What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study, BMJ OpenBMJ Open, vol. 1, p. e000372, 2011.
2010
M. P. Gallagher, A. Cass, and J. C. Craig, Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management, Nephrology (Carlton)Nephrology (Carlton), vol. 15, pp. 429-33, 2010.
M. Jardine, T. Ninomiya, A. Cass, F. Turnbull, M. P. Gallagher, S. Zoungas, H. L. Heerspink, J. Chalmers, AC, A. Zanchetti, and V. Perkovic, Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 49., Perth, Australia, September, 2010.
M. Jardine, T. Ninomiya, V. Perkovic, A. Cass, F. Turnbull, M. P. Gallagher, S. Zoungas, H. J. Lambers Heerspink, J. Chalmers, AC, and A. Zanchetti, Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial, Journal of the American College of CardiologyJournal of the American College of Cardiology, vol. 56, pp. 956-65, 2010.
S. Chadban, M. Howell, S. Twigg, M. Thomas, G. Jerums, A. Cass, D. Campbell, K. Nicholls, A. Tong, G. Mangos, A. Stack, R. J. MacIsaac, S. Girgis, R. Colagiuri, S. Colagiuri, and J. Craig, Assessment of kidney function in type 2 diabetes, NephrologyNephrology, vol. 15, pp. S146-S161, 2010.
E. L. Heeley, D. Peiris, A. A. Patel, A. Cass, A. Weekes, C. Morgan, C. Anderson, and J. Chalmers, AC, Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study), Med J AustMedical Journal of Australia, vol. 192, pp. 254-9, 2010.
A. Tong, K. Howard, S. Jan, A. Cass, J. Rose, S. Chadban, R. D. Allen, and J. C. Craig, Community preferences for the allocation of solid organs for transplantation: a systematic review, Transplantation, vol. 89, pp. 796-805, 2010.
S. Chadban, M. Howell, S. Twigg, M. Thomas, G. Jerums, A. Cass, D. Campbell, K. Nicholls, A. Tong, G. Mangos, A. Stack, R. J. MacIsaac, S. Girgis, R. Colagiuri, S. Colagiuri, and J. Craig, Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes, NephrologyNephrology, vol. 15, pp. S195-S203, 2010.
K. Howard, S. L. White, G. Salkeld, S. McDonald, J. C. Craig, S. Chadban, and A. Cass, Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis, Value HealthValue in Health, vol. 13, pp. 196-208, 2010.
A. Cass, Diabetes, heart and kidney disease: The health reform challenge we must address. Australian Diabetes Educator Association ACT Branch Conference, Canberra, February 2010., in Australian Diabetes Educator Association ACT Branch Conference, Canberra, Australia, February, 2010.
H. J. Heerspink, T. Ninomiya, V. Perkovic, M. Woodward, S. Zoungas, A. Cass, M. Cooper, D. E. Grobbee, G. Mancia, C. E. Mogensen, B. Neal, and J. Chalmers, AC, Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease, European Heart JournalEuropean Heart Journal, vol. 31, pp. 2888-96, 2010.
M. Jun, C. Foote, J. Lv, B. Neal, A. Patel, S. J. Nicholls, D. E. Grobbee, A. Cass, J. Chalmers, AC, and V. Perkovic, Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis, Lancet, vol. 375, pp. 1875-84, 2010.
T. Ninomiya, S. Zoungas, B. Neal, M. Woodward, A. Patel, V. Perkovic, A. Cass, M. Cooper, D. Grobbee, P. Hamet, S. Harrap, L. Liu, G. Mancia, C. E. Mogensen, N. Poulter, A. Rodgers, B. Williams, S. MacMahon, and J. Chalmers, AC, Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial, J HypertensJournal of Hypertension, vol. 28, pp. 1141-9, 2010.
C. Foote, T. Ninomiya, M. P. Gallagher, V. Perkovic, A. Cass, S. McDonald, and M. Jardine, Factors associated with survival in elderly dialysis patients, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 27., Perth, Australia, September, 2010.

Pages